Centogene N.V. Second Registration Rights Agreement October 26, 2023Second Registration Rights Agreement • October 27th, 2023 • Centogene N.V. • Services-medical laboratories • New York
SECOND REGISTRATION RIGHTS AGREEMENT, dated as of October 26, 2023, to be effective as of the Closing Date (as defined below), between Centogene N.V., a public company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Borrower”), and the Lender signatory hereto.
AMENDMENT TO SECOND REGISTRATION RIGHTS AGREEMENTSecond Registration Rights Agreement • May 15th, 2024 • Centogene N.V. • Services-medical laboratories
THIS AMENDMENT TO SECOND REGISTRATION RIGHTS AGREEMENT (this “Amendment”) is made and entered into as of May 12, 2024, by and between Centogene N.V., a public company with limited liability (naamloze vennootschap) incorporated under the laws of the Netherlands (the “Borrower”), and Pharmaceutical Investment Company, a closed joint stock company incorporated pursuant to the laws of the Kingdom of Saudi Arabia (the “Lender”). Capitalized terms used but not otherwise defined herein shall have the respective meanings assigned to such terms in the Registration Rights Agreement.
